Minomic Signs Agreement with US Pathology Laboratory

Minomic Signs Agreement with US Pathology Laboratory

Agreement enables early access to the MiCheck® Prostate Cancer Test for US Clinicians & Patients February 14, 2019: [Sydney] Minomic International Ltd is pleased to announce the company has executed an agreement with Cirrus Dx, a CLIA Certified “High Complexity”...
Minomic secures key patent in the United States and China

Minomic secures key patent in the United States and China

Facebook Twitter Google+ LinkedIn Minomic has received a Notice of Allowance for the company’s patent covering its cell surface antigen for the diagnosis of prostate cancer Sydney, Australia, 5 September 2018: Minomic International Ltd (Minomic), an immuno-oncology...